Search Results - "Williams, Shelly M."
-
1
Tumor Lysis Syndrome
Published in Archives of pathology & laboratory medicine (1976) (01-03-2019)“…Tumor lysis syndrome (TLS) is an acute, life-threatening disease among adults and children that is associated with the initiation of cytoreductive therapy in…”
Get full text
Journal Article -
2
Characteristics of HPC(A) product obtained from a donor with SARS-CoV-2 infection and outcome of autologous transplant
Published in Stem cell research & therapy (13-08-2024)“…Collection of hematopoietic progenitor cell products [HPC(A)] is deferred if the donor is symptomatic and tests positive for Covid-19. However, donor…”
Get full text
Journal Article -
3
Identification of Genes Responsible for Osteoblast Differentiation from Human Mesodermal Progenitor Cells
Published in Proceedings of the National Academy of Sciences - PNAS (18-03-2003)“…Single human bone marrow-derived mesodermal progenitor cells (MPCs) differentiate into osteoblasts, chondrocytes, adipocytes, myocytes, and endothelial cells…”
Get full text
Journal Article -
4
Handling the different requirements for commercial and investigational MNC collections by apheresis
Published in Cytotherapy (Oxford, England) (01-08-2024)“…With the success of chimeric antigen receptor T-cell (CAR-T) and similar cellular-based therapies, the demand for collection of autologous mononuclear cells by…”
Get full text
Journal Article -
5
Two acute psychiatric emergencies and prevalence of mental health disorders at an outpatient apheresis clinic: Implications for apheresis practitioners
Published in Journal of clinical apheresis (01-02-2023)“…The prevalence of mental health disorders among apheresis patients is unknown. Patients with chronic conditions treated with apheresis in the outpatient…”
Get full text
Journal Article -
6
Infusion reactions in natural killer cell immunotherapy: a retrospective review
Published in Cytotherapy (Oxford, England) (01-07-2021)“…The use of natural killer (NK) cells as a cellular immunotherapy has increased over the past decade, specifically in patients with hematologic malignancies. NK…”
Get full text
Journal Article -
7
Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution
Published in Transfusion (Philadelphia, Pa.) (01-06-2018)“…BACKGROUND Allogeneic natural killer (NK) cell adoptive immunotherapy is a growing therapeutic option for patients. Clinical‐scale production of NK cells using…”
Get full text
Journal Article -
8
The BEST criteria improve sensitivity for detecting positive cultures in residual blood components cultured in suspected septic transfusion reactions
Published in Transfusion (Philadelphia, Pa.) (01-07-2019)“…BACKGROUND Culturing residual blood components after suspected septic transfusion reactions guides management of patients and cocomponents. Current practice,…”
Get full text
Journal Article -
9
-
10
Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program
Published in Global pediatric health (2017)“…Objective: To pilot a newborn screening program for sickle cell disease (SCD) in St. Vincent and the Grenadines using a novel partnership method to determine…”
Get full text
Journal Article